TT. I don’t see any major uplift in sales without public reimbursement. Tripps may expand the label but it won’t lead to public reimbursement. And you can’t get public reimbursement without FDA approval. And there is no FDA trial for LAPC.
OSL Price at posting:
0.7¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)